Mentions
Extended reach
Total likes
Video views
AI synopsis
These discussions reveal a positive reception to the trial, with comments like the reduction of biopsies potentially saving costs and improving patient care, demonstrating curiosity and hope for broader clinical adoption. The tone is professional and supportive, with mentions of key figures like Professor Bhandari and emphasis on the trial’s significance, reflecting shared interest and engagement in advancing gastroenterological practices.
Most discussions highlight support for the trial, emphasizing potential benefits like cost savings and improved patient experience, indicating general agreement with the findings.
The discussions show high interest, with notable admiration for the research work and its implications, especially around the potential for clinical improvements.
Participants reference specific aspects of the trial, such as feasibility and cost-effectiveness, suggesting active engagement with the content.
While optimistic about future applications, most posts remain cautiously optimistic, implying some expectation of impact but awaiting further evidence.
Very proud to have been part of the Portsmouth Research Team - a really important piece of work which can help improve the experience of patients with Barrett’s oesophagus and save the NHS money from reduced no’s of biopsies! https://t.co/ccGGFJH54a
“A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillance: the ABBA trial” by Gaius Longcroft-Wheaton et al. Read more here: https://t.co/PO2BOzDYgg https://t.co/FU0hT91BwM
@drkeithsiau @SanchezLunaMD @ScopingSundays @KM_Pawlak @AllonKahn @RobertoSimonsMD @vaibhav_manu @rmulkimd @AhmadBazarbashi @PerelmansPearls @BilalMohammadMD @NnekaUfereMD @LizzieAbyMD @DrMalSimons @KellyHathornMD @Scopesdoc @stevenbollipo @CarvalloP_MD @peyoungmd @ViryOregel “.....The reduced numbers of biopsies suggest that the acetic acid technique could result in cost savings, providing the lack of missed pathology can be proven in a fully powered definitive trial.” https://t.co/6IooxWibNV
RT @RodriguezParra_: @drkeithsiau @SanchezLunaMD @ScopingSundays @KM_Pawlak @AllonKahn @RobertoSimonsMD @vaibhav_manu @rmulkimd @AhmadBazar…
RT @endoscopyjrnl: “A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillan…
RT @Lisagadeke: Very proud to have been part of the Portsmouth Research Team - a really important piece of work which can help improve the…
Pradeep Bhandari discusses a study assessing the feasibility of acetic acid-targeted biopsies in Barrett's surveillance, showing potential to significantly reduce biopsies needed while maintaining diagnostic accuracy…
RT @RodriguezParra_: @drkeithsiau @SanchezLunaMD @ScopingSundays @KM_Pawlak @AllonKahn @RobertoSimonsMD @vaibhav_manu @rmulkimd @AhmadBazar…
@drkeithsiau @SanchezLunaMD @ScopingSundays @KM_Pawlak @AllonKahn @RobertoSimonsMD @vaibhav_manu @rmulkimd @AhmadBazarbashi @PerelmansPearls @BilalMohammadMD @NnekaUfereMD @LizzieAbyMD @DrMalSimons @KellyHathornMD @Scopesdoc @stevenbollipo @CarvalloP_MD @peyoungmd @ViryOregel “.....The reduced numbers of biopsies suggest that the acetic acid technique could result in cost savings, providing the lack of missed pathology can be proven in a fully powered definitive trial.” https://t.co/6IooxWibNV
Great to see Professor Pradeep Bhandari discussing the ABBA feasibility trial of Acetic acid-targeted biopsies versus nontargeted quadrantic biopsies during Barretts surveillance... https://t.co/PSZ9PeCxLJ #gastroenterology #Barretts
RT @Lisagadeke: Very proud to have been part of the Portsmouth Research Team - a really important piece of work which can help improve the…
RT @Lisagadeke: Very proud to have been part of the Portsmouth Research Team - a really important piece of work which can help improve the…
RT @Lisagadeke: Very proud to have been part of the Portsmouth Research Team - a really important piece of work which can help improve the…
Very proud to have been part of the Portsmouth Research Team - a really important piece of work which can help improve the experience of patients with Barrett’s oesophagus and save the NHS money from reduced no’s of biopsies! https://t.co/ccGGFJH54a
RT @endoscopyjrnl: “A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillan…
RT @endoscopyjrnl: “A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillan…
RT @endoscopyjrnl: “A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillan…
RT @endoscopyjrnl: “A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillan…
RT @endoscopyjrnl: “A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillan…
“A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett’s surveillance: the ABBA trial” by Gaius Longcroft-Wheaton et al. Read more here: https://t.co/PO2BOzDYgg https://t.co/FU0hT91BwM
EJ
AM
VW
AV
DM
KK
JO
FC